BIOREGENX, INC. Cost of Revenue
BIOREGENX, INC. (BRGX) reported Cost of Revenue of $77.89 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-05-20
- BIOREGENX, INC. cost of revenue for the quarter ending 2026-03-31 was $77.89K, a 28.62% decline year-over-year.
- BIOREGENX, INC. cost of revenue for the quarter ending 2025-12-31 was $66.87K, a 51.46% decline year-over-year.
- BIOREGENX, INC. cost of revenue for the quarter ending 2025-09-30 was $81.36K, a 28.88% decline year-over-year.
- BIOREGENX, INC. cost of revenue for the quarter ending 2025-06-30 was $93.51K, a 64.60% decline year-over-year.
- BIOREGENX, INC. cost of revenue for fiscal 2025 was $350.86K, a 48.53% decline from fiscal 2024.
- BIOREGENX, INC. cost of revenue for fiscal 2024 was $681.68K, a 38.03% decline from fiscal 2023.
- BIOREGENX, INC. cost of revenue for fiscal 2023 was $1.10M.
- BIOREGENX, INC. cost of revenue for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $77.89K 10-Q · filed 2026-05-20 | $144.75K derived: sum of 2 quarters · filed 2026-05-20 | $226.11K derived: sum of 3 quarters · filed 2026-05-20 | $319.63K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-12-31 | $66.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $148.22K derived: sum of 2 quarters · filed 2026-04-15 | $241.74K derived: sum of 3 quarters · filed 2026-04-15 | $350.86K 10-K · filed 2026-04-15 | |
| 2025-09-30 | $81.36K 10-Q · filed 2025-11-14 | $174.87K derived: sum of 2 quarters · filed 2025-11-14 | $283.99K 10-Q · filed 2025-11-14 | $421.74K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-06-30 | $93.51K 10-Q · filed 2025-08-14 | $202.63K 10-Q · filed 2025-08-14 | $340.38K derived: sum of 3 quarters · filed 2026-05-20 | $454.77K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-03-31 | $109.12K 10-Q · filed 2026-05-20 | $246.87K derived: sum of 2 quarters · filed 2026-05-20 | $361.26K derived: sum of 3 quarters · filed 2026-05-20 | $625.41K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-12-31 | $137.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $252.14K derived: sum of 2 quarters · filed 2026-04-15 | $516.29K derived: sum of 3 quarters · filed 2026-04-15 | $681.68K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $114.39K 10-Q · filed 2025-11-14 | $378.54K derived: sum of 2 quarters · filed 2025-11-14 | $543.93K 10-Q · filed 2025-11-14 | $843.92K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $264.15K 10-Q · filed 2025-08-14 | $429.54K 10-Q · filed 2025-08-14 | $729.53K derived: sum of 3 quarters · filed 2025-08-14 | $952.87K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $165.39K 10-Q · filed 2025-05-15 | $159.35K 10-Q/A · filed 2024-05-29 | $465.37K derived: sum of 2 quarters · filed 2025-05-15 | $688.72K derived: sum of 3 quarters · filed 2025-05-15 | $953.68K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $299.98K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-04-16 | $523.33K derived: sum of 2 quarters · filed 2025-04-16 | $788.29K derived: sum of 3 quarters · filed 2025-04-16 | $1.10M 10-K/A · filed 2025-04-16 | |
| 2023-09-30 | $223.34K 10-Q · filed 2024-11-14 | $488.31K derived: sum of 2 quarters · filed 2024-11-14 | $800.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $264.97K 10-Q · filed 2024-10-09 | $576.66K 10-Q · filed 2024-10-09 | |||
| 2023-03-31 | $311.69K 10-Q/A · filed 2024-10-09 | ||||
| 2022-12-31 | $0.00 10-K · filed 2023-04-04 | ||||
| 2021-12-31 | $554.00 10-K · filed 2023-04-04 |